These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31425444)

  • 1. Monitoring Prenatal Exposure to Buprenorphine and Methadone.
    Di Trana A; La Maida N; Tittarelli R; Huestis MA; Pichini S; Busardò FP; Carlier J
    Ther Drug Monit; 2020 Apr; 42(2):181-193. PubMed ID: 31425444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
    Carlier J; La Maida N; Di Trana A; Huestis MA; Pichini S; Busardò FP
    Ther Drug Monit; 2020 Apr; 42(2):205-221. PubMed ID: 31809406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
    de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
    Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes.
    Concheiro M; Jones HE; Johnson RE; Choo R; Shakleya DM; Huestis MA
    J Anal Toxicol; 2010 Oct; 34(8):498-505. PubMed ID: 21819795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
    Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
    Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
    Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
    Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC; Johnston AM; Crocker AM; Heil SH
    J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
    de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
    Clin Chem; 2011 Mar; 57(3):449-58. PubMed ID: 21245372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Accumulation of Methadone Compared with Buprenorphine in Fetal Rat Brain after Maternal Exposure.
    Kongstorp M; Bogen IL; Stiris T; Andersen JM
    J Pharmacol Exp Ther; 2019 Oct; 371(1):130-137. PubMed ID: 31358559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome.
    Lemon LS; Caritis SN; Venkataramanan R; Platt RW; Bodnar LM
    Epidemiology; 2018 Mar; 29(2):261-268. PubMed ID: 29112519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis.
    Kinsella M; Halliday LOE; Shaw M; Capel Y; Nelson SM; Kearns RJ
    Subst Use Misuse; 2022; 57(9):1400-1416. PubMed ID: 35758300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.